Physiological Response to Time-Restricted Eating: Impact on Insulin Sensitivity, Autophagy, and Systemic Inflammation
Keywords:
time-restricted eating, insulin sensitivity, autophagy, inflammationAbstract
Introduction: Time-restricted eating (TRE) is a form of intermittent fasting with food intake restricted to an 8-hour window, without calorie restriction. Meal timing influences metabolic processes associated with circadian rhythms.
The Aim: To explain the mechanisms through which TRE impacts insulin sensitivity, autophagy, and inflammation.
Material and Methods: A narrative literature review was conducted using PubMed for 2019–2025, with the terms time-restricted eating, insulin sensitivity, autophagy, AMP-activated protein kinase (AMPK), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP). Studies in adults examining TRE and metabolic outcomes were included; studies not addressing TRE or these outcomes were excluded. Experimental studies were used as supplementary sources to explain cellular mechanisms of autophagy.
Results: Clinical studies in humans suggest that TRE may improve certain markers of glucose regulation, while its effects on insulin sensitivity are inconsistent and may depend on meal timing, energy intake, and participant characteristics. The role of AMPK activation and mTORC1 (mammalian target of rapamycin complex 1) inhibition in autophagy regulation during fasting is supported primarily by experimental findings; direct evidence of changes in autophagic flux in humans remains limited. A meta-analysis of clinical studies found a statistically significant reduction in TNF-α, while effects on CRP and interleukin-6 (IL-6) were not statistically significant. Spontaneous reductions in energy intake and body weight complicate the interpretation of TRE effects.
Conclusion: TRE may positively affect certain metabolic parameters, particularly glycemic regulation, while improvements in insulin sensitivity have not been consistently proved across studies. Evidence regarding the direct effects of TRE on autophagy and inflammatory markers in humans stays limited, highlighting the need for further controlled studies.